A clinical trial of BLU-667 for non-small cell lung cancer, medullary thyroid cancer and other RET-altered tumors.
The majority of our care is provided in an outpatient setting using customized therapies ranging from chemotherapy and radiation therapy to advanced technologies like immunotherapy, proton therapy, genetic testing, and genomic sequencing.
Dallas Clinical Trial Location
Texas Oncology – Baylor Charles A. Sammons Cancer Center
3410 Worth St Suite 400
Dallas, TX 75246